Back

Results - Announcements

Sales rise 10.78% to Rs 1689.80 crore

Piramal Pharma standalone net profit rises 1.53% in the March 2025 quarter

15-May-2025, 07:41
Net profit of Piramal Pharma rose 1.53% to Rs 277.27 crore in the quarter ended March 2025 as against Rs 273.08 crore during the previous quarter ended March 2024. Sales rose 10.78% to Rs 1689.80 crore in the quarter ended March 2025 as against Rs 1525.30 crore during the previous quarter ended March 2024.

For the full year,net profit rose 76.73% to Rs 691.40 crore in the year ended March 2025 as against Rs 391.22 crore during the previous year ended March 2024. Sales rose 20.40% to Rs 5285.71 crore in the year ended March 2025 as against Rs 4390.11 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	1689.80	1525.30	11	5285.71	4390.11	20
OPM %	24.65	25.55	-	19.68	14.08	-
PBDT	425.53	415.17	2	1133.23	712.88	59
PBT	364.36	362.67	0	911.14	507.62	79
NP	277.27	273.08	2	691.40	391.22	77